The Framework and Role of the Global Certification (CUMCS)

Article
shutterstock_410413681 – コピー

Audit Focus Areas as Seen by Third-Party Certification Bodies

Introduction

Control Union Medical Cannabis Standard G.A.P. (CUMCS–GAP)

As the CBD and industrial hemp markets continue to expand, interest in international certifications such as GACP and CUMCS is steadily increasing.

The Control Union Medical Cannabis Standard G.A.P. (CUMCS–GAP) is a global certification scheme designed to provide practical support for proper cultivation management within the rapidly growing global medical cannabis industry. Rather than serving merely as a compliance checklist, the standard functions as a practical guide for implementing Good Agricultural Practice (G.A.P.) for medical cannabis at the operational level, which is one of its defining characteristics.

Control Union Medical Cannabis Standard

CUMCS–GAP is built upon multiple internationally recognized public guidelines. First, it is based on the WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants, issued in Geneva in 2003 by the World Health Organization. These guidelines establish fundamental international principles for ensuring the quality, safety, and consistency of medicinal plant raw materials.

Second, the standard references the Guidelines for the Cultivation of Cannabis for Medicinal Purposes issued by the Dutch government in December 2002. The Netherlands’ long-standing experience in operating a medical cannabis system provides valuable practical guidance on cultivation management, traceability, and quality assurance specific to medical use.

Third, CUMCS–GAP incorporates international standards for Good Agricultural Practice (G.A.P.) applicable to agricultural production in general, encompassing sustainability, occupational safety, and environmental management. This approach positions medical cannabis not as an isolated or exceptional crop, but as one managed within the broader framework of international agricultural standards.

In addition, the standard aligns with the European Medicines Agency (EMA) GACP guidelines for herbal starting materials, ensuring consistency with the quality management levels required for pharmaceutical raw materials. By integrating these guidelines, CUMCS–GAP provides a globally recognized common language for cultivation management in medical cannabis.

CUMCS requires comprehensive coverage of the following management areas:

Management Areas Required by the CUMCS Standard

Overview of the CUMCS Standard The CUMCS (Control Union Medical Cannabis Standard) is an international standard aimed at establishing and operating an efficient and reproducible quality assurance (QA) system during the cultivation and initial processing stages of medical cannabis. Its methodology is based on the principle that proper control of cultivation and early processing directly determines the characteristics of the active ingredients in the final product, including quality, consistency, and stability.

  • 1. Genetics and Seedling Management

  • 2. Farm and Facility Suitability

  • 3. Cultivation and Production Process Management

  • 4. Organizational Management

  • 5. Quality and Testing Management

  • 6. Traceability and Documentation

  • 7. Security and Regulatory Compliance

  • 8. Distribution and Logistics Management

Key Audit Focus Areas for Third-Party Certification Bodies

CUMCS serves as a practical framework through which third parties verify and certify how medical cannabis is consistently produced under controlled conditions. Rather than relying solely on test results, the core of CUMCS auditing lies in evaluating the integrity of the quality assurance system across the entire production process.
In the Japanese market, there are risks that cannot be explained by numerical data alone, including:

The Significance of Certification in the Japanese Market

  • Reproducibility of THC testing
  • Changes caused by additives or transportation conditions

 

Third-party certification addresses these challenges by structurally demonstrating:

“Which processes produced these results,
and through what accumulation of management controls they were achieved.”

In this context, CUMCS is increasingly becoming a critical infrastructure for accountability and trust in the Japanese market.

Control Union Japan is participating in the CBD Advent Calendar 2026, organized by Asabis Inc.
This page describes global certification services for businesses handling medical cannabis products. In the field of medical cannabis, only products and businesses that comply with the procedures established by the laws and regulations of each country are permitted to handle such products. We do not provide advisory services or consultations regarding the handling of medical cannabis.